United States Antibiogram: Difference between revisions

Line 63: Line 63:
==See Also==
==See Also==
*[[Antibiotics (Main)]]
*[[Antibiotics (Main)]]
*[[Microbiology (Main)]]


==Source==
==Source==

Revision as of 06:35, 27 February 2014

Organisms Penicillins Anti-Staphylocccal Penicillins Amino-Penicillins Anti-Pseudomonal Penicillins Carbapenems Aztreonam Fluroquinolones
Penicillin G Penicillin V Methicillin Nafcillin/Oxacillin Cloxacillin/Diclox. AMP/Amox Amox/Clav AMP-Sulb Ticarcillin Ticar-Clav Pip-Taxo Piperacillin Doripenem Ertapenem Imipenem Meropenem Aztreonam Ciprofloxacin Ofloxacin Pefloxacin Levofloxacin Moxifloxacin Gemifloxacin Gatifloxacin
Strep, Group A, B, C, G + + + + + + + + + + + + + + + + 0 +/- +/- 0 + + + +
Strep. pneumoniae + + + + + + + + + + + + + + + + 0 +/- +/- 0 + + + +
Viridans strep +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- + + + + 0 0 0 + + + +
Strep. milleri + + + + + + + + + + + + + + + + 0 0 0 + + + +
Enterococcus faecalis + + 0 0 0 + + + +/- +/- + + +/- 0 + +/- 0 ^^ ^^ 0 + + + +
Enterococcus faecium +/- +/- 0 0 0 + + + +/- +/- +/- +/- 0 0 +/- 0 0 0 0 0 0 +/- +/- +/-
Staph. aureus (MSSA) 0 0 + + + 0 + + 0 + + 0 + + + + 0 + + + + + + +
Staph. aureus (MRSA) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +/- +/- +/-
Staph. aureus (CA-MRSA) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +/- +/- +/- +/- +/-
Staph. epidermidis 0 0 + + + 0 0 0 +/- +/- + 0 + + + + 0 + + + + + + +
C. jeikeium 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
L. monocytogenes + 0 0 0 0 + + + '+ + +/- + + 0 + 0 0 + + + +

Key

  • + usually effective clinically or >60% susceptible
  • +/- clinical trials lacking or 30-60% susceptible
  • 0 not effective clinically or <30% susceptible
  • blank data not available

See Also

Source

Sanford Guide to Antimicrobial Therapy 2010